|
⚲
|
| Receptos Inc FKA Receptor Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001463729 |
| Sale | 2009-11-09 ($20.0 M Offered, $12.0 M Sold) |
| Fund | |
| Phone | 8586525712 |
| Address | 10835 Road to The Cure San Diego, 92121 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Robert Nelson | |
| Michael Sheffery | |
| Paul Grayson | |
| William Rastetter | |
| Ed Torres | |
| Raymond Stevens | |
| James Schmidt | |
| Doug Cole | |
| Robert Nelsen |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Enriquez Cabot Juan
✚
|
0.0 | |
|
Ensign Group Inc
✚
|
0.0 | |
|
Ensmann Eric E.
✚
|
0.0 | |
|
Ensysce Biosciences, Inc.
✚
|
0.0 | |
|
Entendre Finance May 2025 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Entergy Arkansas LLC
✚
|
0.0 | |
|
Entergy Corp /DE/
✚
|
0.0 | |
|
Entergy Louisiana LLC
✚
|
0.0 | |
|
Entergy Mississippi LLC
✚
|
0.0 | |
|
Enphase Energy, Inc.
✚
|
0.0 |